Immune system response in pancreatic cancers is sparked by immunotherapy, antibodies, and pancreatic cancer vaccine.

Published Date: 19 Jul 2023

delivering a three-pronged immunotherapy regimen to patients with operable pancreatic cancers that combines the pancreatic cancer vaccine GVAX with the immune checkpoint medication nivolumab and the anti-CD137 agonist urelemab.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Potential targets for treating the most common type of liver cancer in children have been identified by a collaborative study.

2.

Study identifies new approach to protect the brain during radiation therapy

3.

While most cancer screenings won't prolong lives, there are still good reasons to continue screening.

4.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

5.

Radiation therapy for patients with breast cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot